|
CUL3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.16990877990975E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.63145061296655E-12 |
| Normal-vs-Stage2 |
1.373720E-04 |
| Normal-vs-Stage3 |
1.000210E-02 |
| Normal-vs-Stage4 |
8.666200E-02 |
| Stage1-vs-Stage2 |
9.328200E-01 |
| Stage1-vs-Stage3 |
1.921380E-01 |
| Stage1-vs-Stage4 |
3.730200E-01 |
| Stage2-vs-Stage3 |
4.248400E-01 |
| Stage2-vs-Stage4 |
4.823000E-01 |
| Stage3-vs-Stage4 |
9.958200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.05537800720867E-12 |
| Normal-vs-AfricanAmerican |
1.20879999998547E-06 |
| Normal-vs-Asian |
1.018500E-03 |
| Caucasian-vs-AfricanAmerican |
4.365200E-01 |
| Caucasian-vs-Asian |
8.202000E-01 |
| AfricanAmerican-vs-Asian |
9.623200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.7715611723761E-15 |
| Normal-vs-Female |
3.080700E-03 |
| Male-vs-Female |
7.355700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.803600E-04 |
| Normal-vs-Extreme_Weight |
1.04249942012302E-13 |
| Normal-vs-Obese |
1.04940000023035E-07 |
| Normal-vs-Extreme_Obese |
1.645780E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.400780E-01 |
| Normal_Weight-vs-Obese |
7.786600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.181800E-01 |
| Extreme_Weight-vs-Obese |
1.011840E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.509800E-01 |
| Obese-vs-Extreme_Obese |
9.153000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.851900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.19790000141506E-08 |
| Normal-vs-Age(61-80Yrs) |
1.68398628375144E-12 |
| Normal-vs-Age(81-100Yrs) |
1.489700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.039400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.037600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.292000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.739900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.587800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.208200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.75937042712349E-12 |
| Normal-VS-Type2 PRCC |
1.63700000221922E-08 |
| Normal-VS-KIRP CIMP |
5.940000E-01 |
| Normal-VS-Unclassified PRCC |
3.042700E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.018200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.669750E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.044600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.712200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.922600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.033760E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.20841139714412E-12 |
| Normal-vs-N1 |
7.817000E-01 |
| Normal-vs-N2 |
5.633800E-04 |
| N0-vs-N1 |
1.864310E-03 |
| N0-vs-N2 |
6.239600E-01 |
| N1-vs-N2 |
1.039800E-02 |
|
|
